Atlas Trials

Safety and Treatment Effect of QBECO in Moderate to Severe Crohn's Disease

Clinical trial NCT01809275 · COMPLETED

Trial details

NCT number
NCT01809275
Sponsor
Qu Biologics Inc.
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Crohn's DiseaseInflammatory Bowel Disease
Start date
2013-03-01
Primary completion
2016-02-01
Enrollment
68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.